LAZERTINIB
UNII 4A2Y23XK11

Substance Identification & Data

This profile provides standardized clinical and technical data for Lazertinib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4A2Y23XK11.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1903008-80-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

4A2Y23XK11

CAS Registry Number

1903008-80-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LAZERTINIB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

4A2Y23XK11

The specific atomic composition represented as a molecular structure string.

InChIKey

C30H34N8O3

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

RRMJMHOQSALEJJ-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C148147

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

121269225

Unique identification number in the NCBI database of chemical substances.

INN ID

10587

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

HI-167

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1c(c(nn1-c2ccnc(Nc3cc(NC(=O)C=C)c(N4CCOCC4)cc3OC)n2)-c5ccccc5)CN(C)C

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lazertinib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.